Zhang Conghui, Wang Hao, Nie Jing, Wang Fang
Department of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
Discov Med. 2014 Sep;18(98):105-12.
The earliest and most significant change in diabetic retinopathy (DR) is blood-retinal barrier (BRB) dysfunction, followed by two main pathologies that may cause severe visual impairment: Diabetic Macular Edema (DME) and Proliferative Diabetic Retinopathy (PDR). The pathological hallmarks of BRB dysfunction include loss of tight junction integrity, VEGF- and AGE-induced damage, oxidative stress, and inflammatory changes. Recently, several BRB protective factors have been reported. Our aim is to give a review of those protective factors and discuss new potential therapeutic targets for DR.
糖尿病视网膜病变(DR)最早且最显著的变化是血视网膜屏障(BRB)功能障碍,随后是两种可能导致严重视力损害的主要病理情况:糖尿病性黄斑水肿(DME)和增殖性糖尿病视网膜病变(PDR)。BRB功能障碍的病理特征包括紧密连接完整性丧失、VEGF和AGE诱导的损伤、氧化应激和炎症变化。最近,有几种BRB保护因子被报道。我们的目的是对这些保护因子进行综述,并讨论DR新的潜在治疗靶点。